Stacy Price
Direttore Tecnico/Scientifico/R&S presso INVIVYD, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Stacy Price
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INVIVYD, INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2023 | - |
Storia della carriera di Stacy Price
Precedenti posizioni note di Stacy Price
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AKOUOS | Direttore Tecnico/Scientifico/R&S | 01/11/2021 | - |
| ALAUNOS THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Stacy Price
| Tufts University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Stacy Price
- Esperienza
